Skip to search.
 TSX Down 0.42% TSX Ventures Down 1.40%

Amgen Inc. (AMGN)

-NasdaqGS
171.63 Down 1.90(1.09%) 4:00PM EDT
|After Hours : 171.63 0.00 (0.00%) 6:09PM EDT - Nasdaq Real Time Price
Prev Close:173.53
Open:170.24
Bid:168.12 x 100
Ask:171.67 x 100
1y Target Est:190.56
Beta:1.3419
Earnings Date:Oct 26 - Oct 31 (Est.)
Day's Range:169.50 - 171.98
52wk Range:131.43 - 176.85
Volume:4,797,526
Avg Vol (3m):2,847,720
Market Cap:128.44B
P/E (ttm):17.56
EPS (ttm):9.77
Div & Yield:4.00 (2.29%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AMGNDown 1.09%128.44B
JNJUp 1.22%326.17B

Key Statistics

Forward P/E (1 yr):13.75
P/S (ttm):5.78
Ex-Dividend Date:15-Aug-16

Analysts

Annual EPS Est (Dec-16) :11.36
Quarterly EPS Est (Sep-16) :2.80
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):1.95

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of illness in the areas of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback